Imlifidase

Imlifidase is an IgG-inactivating therapy based on a cysteine protease originating from Streptococcus pyogenes.

It is designed to have a unique mechanism of action and a high specificity to IgG antibodies. The use of imlifidase is a novel approach to eliminate pathogenic IgG. Given its rapid onset of action, imlifidase cleaves IgG-antibodies and inhibits their activity within hours after administration.